Artal Group’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-4,354,214
| Closed | -$9.75M | – | 89 |
|
|
2024
Q2 | $9.75M | Buy |
4,354,214
+666,666
| +18% | +$1.49M | 0.25% | 39 |
|
|
2024
Q1 | $10.6M | Buy |
3,687,548
+24,444
| +0.7% | +$70.2K | 0.27% | 42 |
|
|
2023
Q4 | $6.48M | Hold |
3,663,104
| – | – | 0.22% | 41 |
|
|
2023
Q3 | $11.6M | Buy |
3,663,104
+2,222,222
| +154% | +$7.02M | 0.5% | 31 |
|
|
2023
Q2 | $952K | Hold |
1,440,882
| – | – | 0.03% | 90 |
|
|
2023
Q1 | $1.15M | Hold |
1,440,882
| – | – | 0.07% | 92 |
|
|
2022
Q4 | $3.26M | Buy |
1,440,882
+400,000
| +38% | +$904K | 0.18% | 71 |
|
|
2022
Q3 | $2.01M | Hold |
1,040,882
| – | – | 0.09% | 91 |
|
|
2022
Q2 | $3.87M | Hold |
1,040,882
| – | – | 0.21% | 64 |
|
|
2022
Q1 | $6.79M | Hold |
1,040,882
| – | – | 0.28% | 66 |
|
|
2021
Q4 | $12.1M | Hold |
1,040,882
| – | – | 0.33% | 57 |
|
|
2021
Q3 | $19.4M | Hold |
1,040,882
| – | – | 0.43% | 50 |
|
|
2021
Q2 | $22.1M | Hold |
1,040,882
| – | – | 0.45% | 43 |
|
|
2021
Q1 | $21.1M | Hold |
1,040,882
| – | – | 0.37% | 51 |
|
|
2020
Q4 | $27.6M | Sell |
1,040,882
-100,000
| -9% | -$2.65M | 0.59% | 41 |
|
|
2020
Q3 | $25.6M | Buy |
+1,140,882
| New | +$25.6M | 0.62% | 32 |
|